JAMA Cardiology,
Lerodalcibep dosed monthly and stable at ambient temperatures significantly reduced LDL-C in patients with CVD or at high risk…
Lerodalcibep dosed monthly and stable at ambient temperatures significantly reduced LDL-C in patients with CVD or at high risk…
Most viewed in the last 7 days from JAMA Cardiology: What is the efficacy and safety of lerodalcibep, a third-gen PCSK9…
Most viewed in the last 7 days from JAMA Cardiology: What is the efficacy and safety of lerodalcibep, a third-gen PCSK9…
Most viewed in the last 7 days from JAMA Cardiology: What is the efficacy and safety of lerodalcibep, a third-gen PCSK9…